Outcome of Board Meeting held on August 3, 2026

OUR ♦ SPECIALITY IS NABH & JCI Accredited ♦ H 0 s p T A L s YOU ♦ A unit of Artemis Medicare Services Ltd. www.artemishospitals.com August 3, 2026 Listing Department, Listing Department, National Stock Exchange of India Limited BSE Limited Exchange Plaza, Bandra-Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Dalal Street, Mumbai – 400 051 Mumbai – 400 001 NSE Symbol: ARTEMISMED Scrip Code: 542919 Dear Sir/Madam, Sub: Outcome of Board Meeting held on August 3, 2026 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we wish to inform you that the Board of Directors at its meeting held today, inter- alia, approved: 1. Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026. 2. Expansion plan of Tower IV in the Company’s flagship Hospital located at Sector-51, Gurugram. The details as required under SEBI Listing Regulations, are provided in “Annexure A”. Pursuant to Regulation 33 of SEBI Listing Regulations, please find enclosed herewith the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026 alongwith limited review reports for the said period issued by the Statutory Auditors of the Company. In terms of Regulation 47 of SEBI Listing Regulations, the extract of the Un-audited Consolidated Financial Results for the quarter ended June 30, 2026, along with the Quick Response (QR) code and the details of the webpage where the complete financial results are accessible, shall be published in the newspapers. The full format of the financial results shall be available on the website of the Stock Exchanges where equity shares of the Company are listed i.e. www.nseindia.com and www.bseindia.com and on Company’s website www.artemishospitals.com. The meeting of the Board of Directors commenced at 3:30 PM and concluded at 4:32 PM. ARTEMIS Artemis Medicare Services Ltd. PHRAPP Corporate Office: Sector 51, Gurugram -122001, Haryana, lndia ARTEMIS VENT\JRES Ph.: +91-124-4511111 I Emergency & Trauma: +91-124-4588 888 I Fa•: +91-124-4588 899 Registered Office: Plot No. 14, Sector 20, Dwarka, New Delhi -110075 I CIN: L85110DL2004PLC126414 J GST: 06AAFCA0130M1Zl (HR), 07AAFCA0130M1ZZ (DEL) I TAN: DELA16048E J PAN: AAFCA0130M J Email: info@artemishospitals.com I Web: www.artemishospitals.com OUR ♦ SPECIALITY IS NABH & JCI Accredited ♦ H 0 s p T A L s YOU ♦ A unit of Artemis Medicare Services Ltd. www.artemishospitals.com You are requested to take the same on your record. Thanking you, Yours faithfully, For Artemis Medicare Services Limited Poonam Makkar Company Secretary & Compliance Officer Encl.: As above ARTEMIS Artemis Medicare Services Ltd. PHRAPP Corporate Office: Sector 51, Gurugram -122001, Haryana, lndia ARTEMIS VENT\JRES Ph.: +91-124-4511111 I Emergency & Trauma: +91-124-4588 888 I Fa•: +91-124-4588 899 Registered Office: Plot No. 14, Sector 20, Dwarka, New Delhi -110075 I CIN: L85110DL2004PLC126414 J GST: 06AAFCA0130M1Zl (HR), 07AAFCA0130M1ZZ (DEL) I TAN: DELA16048E J PAN: AAFCA0130M J Email: info@artemishospitals.com I Web: www.artemishospitals.com CA T R Chadha & Co LLP I ND I A Chartered Accountants Independent Auditor's Review Report on Review of Quarterly Unaudited Standalone Financial Results of Artemis Medicare Services Limited Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended The Board of Directors Artemis Medicare Services Limited 1. We have reviewed the accompanying Statement of Standalone Unaudited Financial Results of Artemis Medicare Services Limited ('the Company') for the quarter ended June 30, 2026, (hereinafter referred to as "Statement"), being submitted by the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended to date (" Listing Regulations"). 2. The Statement, which is the responsibility of the Company's Management and approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34, (Ind AS 34) "Interim Financial Reporting" prescribed under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India. Our responsibility is to express a conclusiun on U1e Statement based on our reviP.w. 3. We conducted our review of the Statement in accordance with the Sta11dard 011 Review E11gage111e11ts (SRE) 2410 'Review of lllterim Fi11a11cial Infor111atio11 performed by the llldepe11de11t Auditor of the Entity', issued by the Institute of Chartered Accountants of India (!CAI). This Standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review of interim financial information consists of making inquiries, primarily of the Company's personnel responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Companies Act, 2013 and consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted and procedures performed as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in all material respects in accordance with applicable Indian Accounting Standards prescribed under Section 133 of the Companies Act, 2013, and other recognized accounting practices and policies, has not disclosed the information required to be disclosed in terms of the Listing Regulations including the manner in which it is to be disclosed, or that it contains any material misstatement. For T R Chadha & Co LLP Chartered Accountants (Firm Regn. No. 006711N/N500028) Name: Neena Goel Partner Membership Number: 057986 Place of signature: Noida Date: 03-Aug-2026 UDIN: 26057986XRTKVQ4710 f R (hadlm & Co LLP, A limned linbili1y pa1t11i::rsl11p \1,,1th LLP ldcnutkauon '-o A \F-3926 '.\mda Branch Office; Plot ,o B-11. fir)!. Floor. <iector-1 ,ou.b-201,01. Gautam Budh '-agar (L. P J Ph 91 l~O -t-199900 Email m,1d:nl trchadha com. ('on,ora1c: Regd Office B• i0, Co1111aught Plai:e. Kulluala Bmld111~ ,e" Delhi - I l000 I Ph '>t 011 4125()900 E-mail Jelh1 a m:hadha com Offices Alnm:dabad I Bcngaluru I Chennm I Gurugram I ll"derabad I \lumba1 I 'c" Delhi I ,oid.i Puue f1rupa11 I Vadodara '"' 11 trchadha com ARTEMIS MEDICARE SERVICES LIMITED CIN: L85110DL2004PLC126414 Registered office: Plot No.14, Sector 20, Dwarka, South West Delhi, Delhi-110075 Ph: +91-124-4511111; Email: investor@artemishospitals.com; Website: www.artemishospitals.com STATEMENT OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2026 (fin Lacs) Quarter ended Year ended 30-Jun-26 31-Mar-26 30-Jun-25 31-Mar-26 S No. Particulars (Audited) (Unaudited) (Unaudited) (Audited) (Refer Note 3) 1. Income (a) Revenue from Operations 28,200.97 27,378.66 24,979.86 1,06,049.17 (b) Other Income 539.58 767.57 695.76 2,990.48 Total Income 28,740.55 28,146.23 25,675.62 1,09,039.65 2. Expenses (a) Operative Expenses 16,519.05 16,019.04 15,444.56 64,091.48 (bl Employee Benefits Expense 4,175.93 4,396.36 3,730.65 16,183.67 (c) Finance Costs 642.20 630.67 710.92 2,694.40 (d) Depreciation and Amortization Expense 1,235.28 1,238.29 I.065.99 4,632.79 (e) Other Expenses 1,957.11 1,934.21 1,716.79 7,261.42 Total Expenses 24,529.57 24,218.57 22,668.91 94,863.76 3. Profit before exceptional items and tax (1·2) 4,210.98 3,927.66 3,006.71 14,175.89 4. Exceptional Items (Impact of Labo [Showing first 8,000 characters — download PDF for full document]